105 related articles for article (PubMed ID: 21875487)
1. [Abnormal expression of RSK-4 and its clinical significance in breast cancer].
Liu JL; Yang HW; Chen ZS; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):452-6. PubMed ID: 21875487
[TBL] [Abstract][Full Text] [Related]
2. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of cytokeratin 19 in bone marrow of patients with breast cancer].
Li BJ; Huang XP; Wei WD; Wang JY; Su XD; Zhang X; Hong WS; Tang J; Zhang LJ; Long H; Yang MT; Rong TH
Ai Zheng; 2005 Jun; 24(6):735-9. PubMed ID: 15946491
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Kim TH; Huh JH; Lee S; Kang H; Kim GI; An HJ
Histopathology; 2008 Jul; 53(1):48-55. PubMed ID: 18479414
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
6. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
7. [Significance of chemokine receptor CXCR3 expression in breast cancer].
Li L; Chen J; Lu ZH; Yu SN; Luo YF; Zhao WG; Ma YH; Jia CW
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):85-8. PubMed ID: 21426802
[TBL] [Abstract][Full Text] [Related]
8. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
10. [Flow cytometric quantitative analysis of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene expressions in invasive breast cancers and their clinical significance].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY; Bi Y; Liu YS; Zhou ZB
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):515-7. PubMed ID: 17147116
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between serum VEGF level and VEGF, COX-2 and MVD expression in breast cancer tissues].
Li EX; Wu YY; Shi F; Wu Y; Guo JJ; Dong DF
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):522-5. PubMed ID: 18069633
[TBL] [Abstract][Full Text] [Related]
13. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
14. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
15. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].
Song YC; Fu SD; Wen XP; Ma ZH; Dang CX
Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745
[TBL] [Abstract][Full Text] [Related]
16. [Expression of small breast epithelial mucin mRNA in peripheral blood of breast cancer patients and its clinical significance].
Yang HW; Cao J; Yang NW; Liu JL; Zhang CM; Chen JS; Hong JS; Jiang Y; Su JJ
Ai Zheng; 2005 Jul; 24(7):842-5. PubMed ID: 16004812
[TBL] [Abstract][Full Text] [Related]
17. [Significance of membrane type-1 matrix metalloproteinase expression in breast cancer].
Yao GY; Yang MT; Rong TH; He P
Ai Zheng; 2004 Nov; 23(11 Suppl):1482-6. PubMed ID: 15566663
[TBL] [Abstract][Full Text] [Related]
18. The expression analysis of periostin in human breast cancer.
Zhang Y; Zhang G; Li J; Tao Q; Tang W
J Surg Res; 2010 May; 160(1):102-6. PubMed ID: 19524268
[TBL] [Abstract][Full Text] [Related]
19. [Study of HOXA5 gene expression in breast carcinoma].
Zeng Y; Yang WT; Zhang GH; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):569-74. PubMed ID: 16468307
[TBL] [Abstract][Full Text] [Related]
20. [Expression of SM22α and its relationship with lymph node metastasis in breast cancer].
MA ZF; CUI NP; SHI JH; WANG HY; SHI SH; WEN M; LI Z
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2545-8. PubMed ID: 21092460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
